The role of regorafenib in metastatic colorectal cancer

Rachel Riechelmann; Axel Grothey

doi:10.1016/S1470-2045(15)70191-9

The role of regorafenib in metastatic colorectal cancer

Rachel Riechelmann, Axel Grothey

Medical Oncology

Research output: Contribution to journal › Comment/debate › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	596-597
Number of pages	2
Journal	The Lancet Oncology
Volume	16
Issue number	6
DOIs	https://doi.org/10.1016/S1470-2045(15)70191-9
State	Published - Jun 1 2015

ASJC Scopus subject areas

Oncology

Access to Document

10.1016/S1470-2045(15)70191-9

Cite this

@article{c534efe8fe6241beb343f2634246877d,

title = "The role of regorafenib in metastatic colorectal cancer",

author = "Rachel Riechelmann and Axel Grothey",

year = "2015",

month = jun,

day = "1",

doi = "10.1016/S1470-2045(15)70191-9",

language = "English (US)",

volume = "16",

pages = "596--597",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "6",

}

TY - JOUR

T1 - The role of regorafenib in metastatic colorectal cancer

AU - Riechelmann, Rachel

AU - Grothey, Axel

PY - 2015/6/1

Y1 - 2015/6/1

UR - http://www.scopus.com/inward/record.url?scp=84930247743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930247743&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(15)70191-9

DO - 10.1016/S1470-2045(15)70191-9

M3 - Comment/debate

C2 - 25981811

AN - SCOPUS:84930247743

SN - 1470-2045

VL - 16

SP - 596

EP - 597

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 6

ER -

The role of regorafenib in metastatic colorectal cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this